Syncom Formulations (India) Limited (BOM:524470)
India · Delayed Price · Currency is INR 16.02
+0.18 (1.14%)
At close: May 26, 2026
BOM:524470 Market Cap
BOM:524470 has a market cap or net worth of 14.68 billion as of May 27, 2026. Its market cap has decreased by -1.08% in one year.
Market Cap
14.68B
Enterprise Value
13.57B
Revenue
5.21B
Ranking
n/a
PE Ratio
19.28
Stock Price
16.02
Market Cap Chart
Since December 31, 2001, BOM:524470's market cap has increased from 267.05M to 14.68B, an increase of 5,398.18%. That is a compound annual growth rate of 17.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 15.06B | 12.26% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 22.15B |
| Amrutanjan Health Care | 16.14B |
| Lincoln Pharmaceuticals | 14.69B |
| Venus Remedies | 14.48B |
| Fredun Pharmaceuticals | 13.94B |
| Shukra Pharmaceuticals | 12.75B |
| TTK Healthcare | 12.62B |
| Wanbury | 9.97B |